MYLAN BRASIL DISTRIBUIDORA — Ampicillin Importer Profile
Pharmaceutical Importer · #15 buyer for Ampicillin · $2.0M import value · 54 shipments · BRAZIL · DGFT Verified
MYLAN BRASIL DISTRIBUIDORA is the #15 importer of Ampicillin from India with $2.0M in import value and 54 verified shipments. MYLAN BRASIL DISTRIBUIDORA holds a 0.8% market share in Ampicillin imports based in BRAZIL. The company sources from 1 verified supplier across 18 formulations shipped to 1 country.
MYLAN BRASIL DISTRIBUIDORA — Ampicillin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ampicillin to MYLAN BRASIL DISTRIBUIDORA?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STERISCIENCE SPECIALTIES PRIVATE LIMITED | $2.0M | 54 | 100.0% |
MYLAN BRASIL DISTRIBUIDORA sources Ampicillin from 1 verified Indian supplier based on 54 customs records. The primary supplier is STERISCIENCE SPECIALTIES PRIVATE LIMITED accounting for 100.0% of imports.
How Does MYLAN BRASIL DISTRIBUIDORA Compare to Nearest Ampicillin Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | AVERROES PHARMACEUTICALSSDN BHD MLY | MALAYSIA | $2.0M | 40 | $50.0K |
| 12 | SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED | TANZANIA | $1.3M | 25 | $50.0K |
| 15 | MYLAN BRASIL DISTRIBUIDORA ★ | BRAZIL | $1.2M | 33 | $36.6K |
| 4 | SBR GROUP OF COMPANIES | LIBERIA | $1.2M | 24 | $50.0K |
| 13 | MYLAN INSTITUTIONAL INC | UNITED STATES | $1.2M | 24 | $50.0K |
MYLAN BRASIL DISTRIBUIDORA ranks #15 among 924 Ampicillin importers from India. Average shipment value of $36.6K compared to the market average of $27.7K. The closest competitors by value are AVERROES PHARMACEUTICALSSDN BHD MLY and SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED.
Where Does MYLAN BRASIL DISTRIBUIDORA Import Ampicillin To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $2.0M | 54 | 100.0% |
MYLAN BRASIL DISTRIBUIDORA imports Ampicillin to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $2.0M.
What Ampicillin Formulations Does MYLAN BRASIL DISTRIBUIDORA Import?
| Formulation | Value | Shipments |
|---|---|---|
| AMPICILLIN AND SULBACTAM FOR INJECTION U | $1.1M | 29 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP | $131.0K | 3 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP2G/1G 30'S BATCH NO:5200442 1399 PACKS | $100.0K | 2 |
| AMPICILLIN AND SULBACTAM DOR INJECTION U | $96.9K | 3 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP(1G/500MG) (30'S) BATCH NO:5200462 (1975 PACKS) | $86.3K | 2 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP1G/500MG 30'S BATCH NO:5200462 1975 PACKS | $86.1K | 2 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP2G/1G 30'S BATCH NO:5200437 1380 PACKS | $61.9K | 2 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP(2G/1G) (30'S) BATCH NO:5200637 (1392PACKS) | $48.9K | 1 |
| AMPICILLIN AND SUBACTAM FOR INJECTION US | $48.9K | 1 |
| AMPICILLIN & SULBACTAM FOR INJECTION USP2G/1G 30'S BATCH NO:5200434 1378 PACKS | $48.3K | 1 |
MYLAN BRASIL DISTRIBUIDORA imports 18 distinct Ampicillin formulations from India. The top formulation is AMPICILLIN AND SULBACTAM FOR INJECTION U with 29 shipments worth $1.1M.
Regulatory Requirements: Importing Ampicillin into Brazil
What MYLAN BRASIL DISTRIBUIDORA and other importers must comply with to import Ampicillin from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Ampicillin
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ampicillin from India and How Much Does MYLAN BRASIL DISTRIBUIDORA Import?
India exported $25.6M worth of Ampicillin through 4,470 shipments from 486 suppliers to 133 countries, serving 924 buyers globally. MYLAN BRASIL DISTRIBUIDORA imports $2.0M of this total, accounting for 0.8% of India's Ampicillin exports with 54 shipments from BRAZIL. This is verified from 54 customs shipment records covering 18 distinct formulations.
What Is the Average Order Value for MYLAN BRASIL DISTRIBUIDORA's Ampicillin Imports?
MYLAN BRASIL DISTRIBUIDORA's average Ampicillin order value is $37.4K per consignment, based on 54 shipments totaling $2.0M. MYLAN BRASIL DISTRIBUIDORA is based in BRAZIL and ranks #15 among all Ampicillin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ampicillin to MYLAN BRASIL DISTRIBUIDORA?
MYLAN BRASIL DISTRIBUIDORA sources Ampicillin from 1 verified Indian supplier: STERISCIENCE SPECIALTIES PRIVATE LIMITED ($2.0M, 100.0%). This is based on 54 customs records.
How Does MYLAN BRASIL DISTRIBUIDORA Compare to Other Ampicillin Importers?
MYLAN BRASIL DISTRIBUIDORA ranks #15 among 924 Ampicillin importers from India with a 0.8% market share. The top 3 importers are ARMAS PHARMACEUTICALS ($7.3M), AORTA COMPANY LIMITED ($3.7M), SPARSH BIO-TECH HEALTHCARE PVT LTD ($2.7M). MYLAN BRASIL DISTRIBUIDORA processed 54 shipments from BRAZIL.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ampicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ampicillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MYLAN BRASIL DISTRIBUIDORA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MYLAN BRASIL DISTRIBUIDORA's capped import value divided by total capped export value for Ampicillin across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching MYLAN BRASIL DISTRIBUIDORA importing Ampicillin, covering 18 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 133+ countries, 924+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ampicillin Import Data for MYLAN BRASIL DISTRIBUIDORA
Access order-level details, pricing data, supplier connections, and competitive analysis for MYLAN BRASIL DISTRIBUIDORA's Ampicillin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MYLAN BRASIL DISTRIBUIDORA
Company Profile
Multiple products · $0 total trade · Multiple categories
MYLAN BRASIL DISTRIBUIDORA × Ampicillin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MYLAN BRASIL DISTRIBUIDORA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ampicillin. For current order-level data, contact TransData Nexus.